Summary
Aurobindo Pharma's subsidiary, Lannett, has launched a generic version of a GSK drug in the U.S. This marks the first product from Aurobindo Pharma's inhalation pipeline to be commercialized in the American market.
Aurobindo's Lannett Launches Generic Version of GSK Drug in US
HyperFast News
Related news
Aurobindo Pharma Launches Generic Advair Diskus in US for Asthma, COPD
19 Sept 2026, 9:59 am · News
Aurobindo Pharma Gains Over 3% as Subsidiary Launches Generic Advair Diskus in US
19 Sept 2026, 9:59 am · News
USFDA Concludes Inspection of Aurobindo Pharma Subsidiary with 4 Observations
19 Sept 2026, 9:59 am · News
